What is Kopran Ltd (KOPRAN) share price today?

Kopran Ltd (KOPRAN) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/KOPRAN for the latest live price, technical analysis, and AI-powered insights.

How to analyse KOPRAN stock?

VestAI provides comprehensive KOPRAN stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Kopran Ltd in?

Kopran Ltd (KOPRAN) is in the Healthcare sector, Pharmaceuticals industry on the NSE.

Kopran Ltd

Q: What is Kopran Ltd's Orion Score?

Kopran Ltd has an Orion Score of 48/100 (Caution) — a fundamentals-based quality & risk score. Kopran Ltd scores 48/100 (Caution) on the Orion Score — weak business quality (41), moderate growth (54), moderate balance-sheet safety (59) and fair valuation (50). A fundamentals-based quality & risk score, not a buy/sell recommendation.

KOPRAN

NSE· Healthcare

₹195.92

-0.04 (-0.02%)

Updated 02:12 pm IST

52W Low · ₹110.2452W High · ₹202.80

Near 52W High

Market Cap

₹912.98L Cr

Volume

4.90L

Prev Close

₹206.66

ISIN

INE082A01010

Orion Score

Fundamentals-based quality & risk · not a recommendation

48/100

Caution

Kopran Ltd scores 48/100 (Caution) on the Orion Score — weak business quality (41), moderate growth (54), moderate balance-sheet safety (59) and fair valuation (50). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 0.7× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 6/9Altman Z Safe(6.80)Beneish M Clean(-2.53)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

51/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.29x — lean balance sheet

QUALITY

Average

ROCE 10.8% — decent returns

MOMENTUM

Bullish

RSI 64.8 — strong momentum

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 35.47
ROCE: 10.75%
ROE (1Y): 4.91%
D/E Ratio: 0.29x
OPM: 15.41%
TTM EPS: ₹5.33
Dividend Yield: 159.00%
Qtrly Sales: ₹234.02 Cr
Qtrly Profit: ₹18.87 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹234.02	₹18.87	15.4%	₹3.91
Q3 2026	₹194.28	₹9.34	8.1%	₹1.93
Q2 2026	₹117.91	₹-9.92	-1.1%	₹-2.06
Q1 2026	₹135.22	₹7.45	7.3%	₹1.54
Q4 2025	₹172.36	₹9.68	7.7%	₹2.00

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2026	₹681.42	₹25.73	₹62.3	8.9%
FY 2025	₹629.6	₹38.55	₹76.88	9.1%
FY 2024	₹614.59	₹50.96	₹86.82	10.0%
FY 2023	₹548.18	₹27.23	₹53.28	8.3%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
KOPRAN ★	₹913 Cr	35.47	10.75%	4.91%	0.29x	15.41%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹90,029 Cr	25.94	12.55%	9.93%	0.21x	15.11%
ABBOTINDIAAbbott India Limited	₹57,724 Cr	36.63	36.14%	34.46%	0.04x	27.01%
AJANTPHARMAjanta Pharma Limited	₹41,836 Cr	39.55	27.99%	25.39%	0.06x	51.40%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹844.01	₹743.25	₹649.7	₹610.89
Equity	₹518.35	₹491.25	₹439.25	₹426.17
Total Debt	₹147.79	₹99.23	₹75.24	₹72.48
Cash	₹19.47	₹8.09	₹7.4	₹5.87
Net Debt	₹128.31	₹91.14	₹67.84	₹66.62
Working Capital	₹220.78	₹235.5	₹222.1	₹263.29

Shareholding Pattern

Q1 FY2027

Promoter

47.44%

FII

0.14%

DII

0.11%

Public

52.31%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	47.44% ↑	0.14% ↓	0.11% ↑	52.31% ↓
Q4 FY2026	44.43%	0.57% ↑	0%	55.01% ↓
Q3 FY2026	44.43%	0.36% ↓	0%	55.21% ↑
Q2 FY2026	44.43%	0.6% ↓	0%	54.99% ↑
Q1 FY2026	44.43%	0.76% ↓	0%	54.81% ↑
Q4 FY2025	44.42% ↓	1.11% ↑	0%	54.45% ↓
Q3 FY2025	44.45% ↓	0.86% ↓	0% ↓	54.68% ↑
Q2 FY2025	44.49%	1.31%	0.22%	53.98%

Corporate Actions

No recent corporate actions

Smart Money Holdings

Q4 FY2025

Investor	Shares Held	Portfolio %	Change
madhusudan-kela	12,00,000	1.10%	—
madhusudan-kela	5,00,000	1.00%	—

Funds Holding This Stock

1 mutual fund schemes

Bandhan BSE Healthcare Index Fund Direct GrowthIDFC

0.04%

₹0 Cr

Analyse KOPRAN with Orion AI

Ask: "Is Kopran Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Kopran Ltd (KOPRAN) Stock

Kopran Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE082A01010. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.